Tag: Brilique

NICE backs long-term use of AZ’ Brilique

by Selina McKee | Nov 4, 2016 | News | 0

The National Institute of Health and Care Excellence (NICE) has now published a Final Appraisal Determination recommending a lower dose of AstraZeneca’s anti-clotting treatment Brilique for longer-term use in the prevention of heart attack and stroke.

NICE looks to expand Brilique reach

by Selina McKee | Aug 12, 2016 | News | 0

Thousands of patients are set to benefit from AstraZeneca’s clot buster Brilique after cost regulators endorsed its longer term use on the NHS to prevent cardiovascular events.